These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28622948)

  • 1. High level of β-(1,3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease.
    Rautemaa V; Green HD; Jones AM; Rautemaa-Richardson R
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):316-321. PubMed ID: 28622948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
    Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
    BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.
    Prattes J; Hoenigl M; Rabensteiner J; Raggam RB; Prueller F; Zollner-Schwetz I; Valentin T; Hönigl K; Fruhwald S; Krause R
    Mycoses; 2014 Nov; 57(11):679-86. PubMed ID: 25040144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
    Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
    Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
    Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of serum human Galactomannan aspergillus antigen and 1,3-beta-D-glucan in immunocompromised patient suspected fungal infection.
    Susianti H; Parmadi L; Firani NK; Setyawan UA; Sartono TR
    J Clin Lab Anal; 2021 Jun; 35(6):e23806. PubMed ID: 33945177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.
    Ceesay MM; Desai SR; Berry L; Cleverley J; Kibbler CC; Pomplun S; Nicholson AG; Douiri A; Wade J; Smith M; Mufti GJ; Pagliuca A
    Br J Haematol; 2015 Jan; 168(2):219-29. PubMed ID: 25179933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of the (1-3)-β-d-glucan assay in patients with different risks for invasive fungal diseases.
    Nham E; Kim SH; Ko JH; Huh K; Cho SY; Kang CI; Chung DR; Peck KR
    Med Mycol; 2024 Aug; 62(8):. PubMed ID: 39030069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.
    Calitri C; Caviglia I; Cangemi G; Furfaro E; Bandettini R; Fioredda F; Amoroso L; Faraci M; Risso FM; Mattioli G; Moscatelli A; Haupt R; Castagnola E
    Mycoses; 2017 Dec; 60(12):789-795. PubMed ID: 28833726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
    Koltze A; Rath P; Schöning S; Steinmann J; Wichelhaus TA; Bader P; Bochennek K; Lehrnbecher T
    J Clin Microbiol; 2015 Aug; 53(8):2605-10. PubMed ID: 26041896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucan rich nutrition does not increase gut translocation of beta-glucan.
    Hoenigl M; Lin J; Finkelman M; Zhang Y; Karris MY; Letendre SL; Ellis RJ; Burke L; Richard B; Gaufin T; Isnard S; Routy JP; Gianella S
    Mycoses; 2021 Jan; 64(1):24-29. PubMed ID: 32780885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections.
    Metan G; Agkus C; Nedret Koc A; Elmali F; Finkelman MA
    Mycoses; 2012 Jul; 55(4):366-71. PubMed ID: 22040530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections.
    Metan G; Koc AN; Ağkuş Ç; Kaynar LG; Alp E; Eser B
    Rev Iberoam Micol; 2012; 29(3):169-71. PubMed ID: 21907303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of serum β-D-glucan levels in recipients of living donor liver transplantation.
    Yamanouchi K; Takatsuki M; Hidaka M; Soyama A; Kanematsu T; Eguchi S
    J Hepatobiliary Pancreat Sci; 2011 May; 18(3):432-5. PubMed ID: 21120672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?
    Nakase K; Suzuki K; Kyo T; Kohara T; Sugawara Y; Katayama N
    Int J Infect Dis; 2012 Jan; 16(1):e2-e4. PubMed ID: 22071235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False positive serum levels of (1-3)-ß-D-Glucan after infusion of intravenous immunoglobulins and time to normalisation.
    Egger M; Prüller F; Raggam R; Divjak MK; Kurath-Koller S; Lackner H; Urban C; Strenger V
    J Infect; 2018 Feb; 76(2):206-210. PubMed ID: 29174967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia.
    Abe M; Kimura M; Araoka H; Taniguchi S; Yoneyama A
    Med Mycol; 2014 Nov; 52(8):835-40. PubMed ID: 25349254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum hepcidin-25 levels in predicting invasive fungal disease in patients after transplantation.
    Chen J; Zhong L
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1769-73. PubMed ID: 23852902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified culture method detects a high diversity of fungal species in cystic fibrosis patients.
    Masoud-Landgraf L; Badura A; Eber E; Feierl G; Marth E; Buzina W
    Med Mycol; 2014 Feb; 52(2):179-86. PubMed ID: 23651180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.